american diabetes association history of pancreatitis glp-1 receptor agonist glucagon-like peptide-1 agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology Frontiers | GLP-1 Receptor Agonists:
Description
Tradjenta [package insert]
doi:10.1007/s00259-019-04409-1 151
[DOI] [PMC free article] [PubMed] [Google Scholar] 96.Knop F.K., Aroda V.R., do Vale R.D., et al
doi: 10.1038/nature02440 55 BeiroaDImbernonMGallegoRSenraAHerranzDVillarroyaFet al
In late April 2022, Eli Lilly released preliminary results from the SURMOUNT-1 trial that included overweight and obese patients using tirzepatide who did not have diabetes
Headaches , fatigue , constipation , and diarrhea are all reported
